Warning letter
Rainbow LTD, Inc. dba PN Medical [ARCHIVED]: warning letter of Nov 1, 2011
FDA warning letter 213973 · Florida District Office
Key facts
| Reference number | 213973 |
|---|---|
| Company | Rainbow LTD, Inc. dba PN Medical [ARCHIVED] |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | Nov 1, 2011 |
| Posted date | Nov 1, 2011 |
| Issuing office | Florida District Office |
| Product type | Devices |
| CFR sections cited | 803, 803.17, 807.81(a)(3)(ii), 820, 807.81(b) |
| Inspection city | Orlando |
| Inspection ZIP | 32801 |
| Inspection start date | Jun 23, 2011 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: